HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk.

AbstractOBJECTIVE:
Individuals with impaired glucose tolerance (IGT) are at high risk for developing type 2 diabetes mellitus (T2DM). We examined which characteristics at baseline predicted the development of T2DM versus maintenance of IGT or conversion to normal glucose tolerance.
RESEARCH DESIGN AND METHODS:
We studied 228 subjects at high risk with IGT who received treatment with placebo in ACT NOW and who underwent baseline anthropometric measures and oral glucose tolerance test (OGTT) at baseline and after a mean follow-up of 2.4 years.
RESULTS:
In a univariate analysis, 45 of 228 (19.7%) IGT individuals developed diabetes. After adjusting for age, sex, and center, increased fasting plasma glucose, 2-h plasma glucose, G0-120 during OGTT, HbA1c, adipocyte insulin resistance index, ln fasting plasma insulin, and ln I0-120, as well as family history of diabetes and presence of metabolic syndrome, were associated with increased risk of diabetes. At baseline, higher insulin secretion (ln [I0-120/G0-120]) during the OGTT was associated with decreased risk of diabetes. Higher β-cell function (insulin secretion/insulin resistance or disposition index; ln [I0-120/G0-120 × Matsuda index of insulin sensitivity]; odds ratio 0.11; P < 0.0001) was the variable most closely associated with reduced risk of diabetes.
CONCLUSIONS:
In a stepwise multiple-variable analysis, only HbA1c and β-cell function (ln insulin secretion/insulin resistance index) predicted the development of diabetes (r = 0.49; P < 0.0001).
AuthorsRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, Maryann Banerji, George A Bray, Thomas A Buchanan, Stephen C Clement, Robert R Henry, Abbas E Kitabchi, Sunder Mudaliar, Robert E Ratner, Frankie B Stentz, Nicolas Musi, Peter D Reaven, Amalia Gastaldelli, ACT NOW Study
JournalDiabetes care (Diabetes Care) Vol. 36 Issue 11 Pg. 3607-12 (Nov 2013) ISSN: 1935-5548 [Electronic] United States
PMID24062330 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Blood Glucose
  • Insulin
Topics
  • Blood Glucose (metabolism)
  • Diabetes Mellitus, Type 2 (blood, epidemiology)
  • Fasting
  • Female
  • Glucose Intolerance (blood, epidemiology)
  • Glucose Tolerance Test
  • Humans
  • Insulin (blood)
  • Insulin Resistance (physiology)
  • Insulin-Secreting Cells (metabolism)
  • Male
  • Metabolic Syndrome (complications)
  • Middle Aged
  • Risk

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: